Jianping Hu
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Protein Degradation and Inhibitors 3
- Melanoma and MAPK Pathways 2
-
- Cardiac electrophysiology and arrhythmias 2
- Co-authors
- Jian Jin (3 shared papers)Xinyu Liu (1 shared paper)Jinen Song (1 shared paper)Xiang Chen (1 shared paper)Xiaowei Liu (1 shared paper)Hao Zhang (1 shared paper)Yunuo Zhao (1 shared paper)Hu Zhang (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Frontiers in Oncology (1 paper)Aging (1 paper)Renal Failure (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Jianping Hu
12 papers receiving 507 citations
Jianping Hu's Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 198
- Immunology 122
- Hematology 46
- Cancer Research 55
- Molecular Biology 243
Countries citing papers authored by Jianping Hu
This map shows the geographic impact of Jianping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Hu more than expected).
Fields of papers citing papers by Jianping Hu
This network shows the impact of papers produced by Jianping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Hu. The network helps show where Jianping Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianping Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance Hit paper breakdown → | 2023 | 217 |
| 2 | 2011 | 110 | |
| 3 | 2022 | 64 | |
| 4 | 2019 | 54 | |
| 5 | 2020 | 29 | |
| 6 | 2013 | 20 | |
| 7 | 2023 | 6 | |
| 8 | 2012 | 3 | |
| 9 | 2017 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2025 | 1 |
About Jianping Hu
Jianping Hu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Epidemiology and Hematology, having authored 12 papers that have together received 511 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Melanoma and MAPK Pathways (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Multiple Myeloma Research and Treatments (2 papers), Immune cells in cancer (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Oncology (198 citations), Immunology (122 citations), Hematology (46 citations), Cancer Research (55 citations) and Molecular Biology (243 citations). Jianping Hu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Jian Jin, Xinyu Liu, Jinen Song, Xiang Chen, Xiaowei Liu, Hao Zhang, Yunuo Zhao, Hu Zhang, Qinhe Yang and Jing Hao. Their work appears in journals such as Journal of Medicinal Chemistry, Frontiers in Oncology, Aging, Renal Failure and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.